NEW YORK (Reuters) – Novartis AG (NOVN.S) agreed to pay $678 million to settle a civil fraud lawsuit brought by the U.S. government [...]
This website uses cookies to improve your user experience and to provide you with advertisements that are relevant to your interests. By continuing to browse the site you are agreeing to our use of cookies.Ok